Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $3.43 billion. The enterprise value is $2.92 billion.
| Market Cap | 3.43B |
| Enterprise Value | 2.92B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 249.44 million shares outstanding. The number of shares has increased by 14.13% in one year.
| Current Share Class | 249.44M |
| Shares Outstanding | 249.44M |
| Shares Change (YoY) | +14.13% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 1.67% |
| Owned by Institutions (%) | 46.00% |
| Float | 123.62M |
Valuation Ratios
The trailing PE ratio is 49.19 and the forward PE ratio is 23.85. Cellebrite DI's PEG ratio is 1.21.
| PE Ratio | 49.19 |
| Forward PE | 23.85 |
| PS Ratio | 6.91 |
| Forward PS | 5.79 |
| PB Ratio | 6.64 |
| P/TBV Ratio | 13.05 |
| P/FCF Ratio | 21.64 |
| P/OCF Ratio | 19.89 |
| PEG Ratio | 1.21 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.70, with an EV/FCF ratio of 18.41.
| EV / Earnings | 40.93 |
| EV / Sales | 5.88 |
| EV / EBITDA | 36.70 |
| EV / EBIT | 46.12 |
| EV / FCF | 18.41 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.54 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.44% and return on invested capital (ROIC) is 61.48%.
| Return on Equity (ROE) | 16.44% |
| Return on Assets (ROA) | 4.76% |
| Return on Invested Capital (ROIC) | 61.48% |
| Return on Capital Employed (ROCE) | 10.52% |
| Weighted Average Cost of Capital (WACC) | 10.63% |
| Revenue Per Employee | $386,325 |
| Profits Per Employee | $55,526 |
| Employee Count | 1,285 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 9.71 |
Taxes
In the past 12 months, Cellebrite DI has paid $13.12 million in taxes.
| Income Tax | 13.12M |
| Effective Tax Rate | 15.44% |
Stock Price Statistics
The stock price has decreased by -15.27% in the last 52 weeks. The beta is 1.17, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -15.27% |
| 50-Day Moving Average | 13.23 |
| 200-Day Moving Average | 15.63 |
| Relative Strength Index (RSI) | 56.04 |
| Average Volume (20 Days) | 2,263,142 |
Short Selling Information
The latest short interest is 5.50 million, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 5.50M |
| Short Previous Month | 4.14M |
| Short % of Shares Out | 2.21% |
| Short % of Float | 4.45% |
| Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $496.43 million and earned $71.35 million in profits. Earnings per share was $0.28.
| Revenue | 496.43M |
| Gross Profit | 416.33M |
| Operating Income | 63.33M |
| Pretax Income | 84.98M |
| Net Income | 71.35M |
| EBITDA | 79.57M |
| EBIT | 63.33M |
| Earnings Per Share (EPS) | $0.28 |
Balance Sheet
The company has $429.07 million in cash and $22.81 million in debt, giving a net cash position of $511.75 million or $2.05 per share.
| Cash & Cash Equivalents | 429.07M |
| Total Debt | 22.81M |
| Net Cash | 511.75M |
| Net Cash Per Share | $2.05 |
| Equity (Book Value) | 510.54M |
| Book Value Per Share | 2.07 |
| Working Capital | 190.66M |
Cash Flow
In the last 12 months, operating cash flow was $172.55 million and capital expenditures -$13.93 million, giving a free cash flow of $158.62 million.
| Operating Cash Flow | 172.55M |
| Capital Expenditures | -13.93M |
| Depreciation & Amortization | 16.24M |
| Net Borrowing | n/a |
| Free Cash Flow | 158.62M |
| FCF Per Share | $0.64 |
Margins
Gross margin is 83.86%, with operating and profit margins of 12.76% and 14.48%.
| Gross Margin | 83.86% |
| Operating Margin | 12.76% |
| Pretax Margin | 17.12% |
| Profit Margin | 14.48% |
| EBITDA Margin | 16.03% |
| EBIT Margin | 12.76% |
| FCF Margin | 31.95% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.13% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.08% |
| FCF Yield | 4.62% |
Analyst Forecast
The average price target for Cellebrite DI is $21.00, which is 52.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 52.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 18.08% |
| EPS Growth Forecast (3Y) | 16.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 6.36 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.36 |
| Piotroski F-Score | 4 |